Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Tilray Brands, Inc. is a global consumer packaged goods company focused on cannabis, beverage alcohol, and wellness products. The company operates across the regulated medical and adult-use cannabis industries while also maintaining a significant presence in the craft beer, spirits, and wellness sectors. Tilray’s primary revenue drivers include the cultivation and sale of cannabis products, branded alcoholic beverages, and hemp-derived foods and supplements. Its customers span medical patients, adult-use consumers, distributors, and retail partners across multiple regulated markets.
Originally founded in 2013 as Tilray, Inc., the company gained early prominence as one of the first cannabis producers to supply medical cannabis internationally. In 2021, Tilray merged with Aphria Inc., forming the current Tilray Brands, Inc., which significantly expanded scale, distribution capabilities, and product diversification. The company positions itself as a diversified platform designed to weather cannabis market volatility while leveraging consumer branding, global distribution, and regulatory expertise.
Business Operations
Tilray operates through several major business segments, including Cannabis, Beverage Alcohol, and Distribution and Wellness. The Cannabis segment encompasses the cultivation, processing, and sale of medical and adult-use cannabis products, including dried flower, vapes, edibles, and extracts. The Beverage Alcohol segment includes craft beer and spirits production and distribution, while the Distribution and Wellness segment focuses on hemp-based foods, nutraceuticals, and pharmaceutical distribution, particularly in Europe.
The company maintains vertically integrated operations in key markets, controlling cultivation facilities, manufacturing assets, and branded sales channels. Major subsidiaries include Tilray Medical, Aphria Deutschland, SweetWater Brewing Company, Montauk Brewing Company, and Manitoba Harvest. Tilray also benefits from long-term distribution relationships, including pharmaceutical wholesalers in Europe, and operates under strict regulatory frameworks in each jurisdiction where it sells cannabis.
Strategic Position & Investments
Tilray’s strategy centers on diversification, cost discipline, and global optionality in anticipation of evolving cannabis regulations, particularly in the United States. Growth initiatives include expanding its beverage alcohol portfolio, increasing cannabis market share in Canada and Europe, and maintaining readiness for potential U.S. THC legalization through hemp-derived and alcohol platforms. The company emphasizes cross-brand synergies, shared distribution infrastructure, and balance sheet management.
Notable acquisitions have included Aphria Inc., which transformed Tilray into one of the largest global cannabis companies by revenue, as well as SweetWater Brewing Company, Montauk Brewing Company, and Breckenridge Distillery, strengthening its U.S. consumer packaged goods footprint. Tilray continues to invest in cannabis research, medical trials, and product innovation, while selectively participating in emerging sectors such as cannabis-infused beverages and functional wellness products. Some long-term U.S. cannabis expansion plans remain contingent on regulatory changes; data inconclusive based on available public sources regarding timing.
Geographic Footprint
Tilray Brands is headquartered in New York, United States, with significant operational roots in Canada following the Aphria merger. The company has a broad international presence spanning North America, Europe, Latin America, and Australia, making it one of the most geographically diversified cannabis companies globally. Canada and the United States represent the largest revenue contributors, with Europe serving as a key growth region for medical cannabis and pharmaceutical distribution.
In Europe, Tilray operates cultivation, processing, and distribution facilities in countries including Germany, Portugal, and Italy, supplying regulated medical markets. The company also maintains export and licensing activities in Latin America and Australia, positioning itself to benefit from incremental legalization and medical adoption worldwide.
Leadership & Governance
Tilray Brands is led by an executive team with experience in consumer packaged goods, pharmaceuticals, and regulated industries. The leadership emphasizes disciplined capital allocation, brand building, and regulatory compliance, with a stated vision of becoming a leading global lifestyle and wellness company anchored in cannabis and adjacent consumer categories.
Key executives include:
- Irwin D. Simon – Chairman and Chief Executive Officer
- Carl Merton – Chief Financial Officer
- Denise Faltischek – Chief Strategy Officer and Head of International
- Amit Duvdevani – President, Tilray Cannabis
- Erica Terry – Chief Human Resources Officer
The board and management team oversee governance in accordance with U.S. public company standards, with strategic oversight informed by regulatory complexity and international operations.